NVWM, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
NVWM, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$289,422
-30.7%
6,974
+0.5%
0.09%
-32.9%
Q1 2023$417,372
-42.5%
6,940
-29.9%
0.14%
-47.0%
Q4 2022$726,385
-3.8%
9,903
-0.2%
0.26%
-12.0%
Q3 2022$755,000
+9.4%
9,927
-0.1%
0.30%
+11.9%
Q2 2022$690,000
-16.2%
9,9330.0%0.27%
+2.7%
Q1 2022$823,000
+8.6%
9,933
-1.5%
0.26%
+10.6%
Q4 2021$758,000
-35.3%
10,0890.0%0.24%
-44.1%
Q3 2021$1,172,000
-46.6%
10,089
+1.9%
0.42%
-46.5%
Q2 2021$2,195,000
+58.7%
9,897
-5.4%
0.79%
+43.7%
Q1 2021$1,383,000
-24.2%
10,466
-0.8%
0.55%
-27.8%
Q4 2020$1,825,000
+43.9%
10,549
-7.4%
0.76%
+27.7%
Q3 2020$1,268,000
+90.1%
11,388
+1.2%
0.60%
+65.7%
Q2 2020$667,000
-13.4%
11,250
-1.6%
0.36%
-32.9%
Q1 2020$770,000
-15.8%
11,433
+5.3%
0.54%
-2.4%
Q4 2019$915,000
+9.2%
10,855
-3.2%
0.55%
+6.4%
Q3 2019$838,000
-6.2%
11,210
-20.7%
0.52%
-4.5%
Q2 2019$893,000
+39.7%
14,128
+6.6%
0.54%
+27.4%
Q1 2019$639,000
+3.6%
13,256
-28.1%
0.42%
-8.4%
Q4 2018$617,000
-35.6%
18,426
+0.7%
0.46%
-23.8%
Q3 2018$958,000
+34.7%
18,291
-19.5%
0.61%
+22.7%
Q2 2018$711,000
+195.0%
22,729
+92.0%
0.49%
+180.7%
Q1 2018$241,000
+5.7%
11,840
+4.8%
0.18%
+1.1%
Q4 2017$228,00011,2980.17%
Other shareholders
NOVOCURE LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders